Dirk Spacek
CMS von Erlach Partners Ltd.2
TMT
Whilst CMS von Erlach Partners Ltd. provides a full service for TMT-related matters, its team possesses a core group of data protection specialists. The firm has extensive experience advising on data protection and GDPR-related issues, as well as procurement, sourcing and fintech matters and its clients include financial institutions, start-ups and tech companies. Dirk Spacek leads the team and has notable expertise in both contentious and non-contentious matters, across a variety of technology and IP-related topics. Alain Raemy ensures the practice is strong in all key related areas through his experience in complex corporate transactions such as M&As, restructurings, venture capital and private equity investments.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Nice to work with and professional.’
‘We value the both client-friendly and professional attitude of Dirk Spacek.’
‘CMS has always processed enquiries and requests quickly and competently.’
‘Dirk Spacek has great knowledge and expertise in the field of technology and IP. He is very responsive and gets things done.’
Key clients
- Aon Schweiz AG
- UCB
- Aequitec AG
- AEW Energie
- mobile Health AG
- nChain Group
- Better Cotton AG
- Bruker
- Hochalpines Institut Ftan AG (HIF)/EIM Global
- Merck AG, Switzerland
- Quadient
- Ratepay GmbH
- Ionity
Work highlights
- Advising mobile Health AG in connection with the Consilium Care system which incorporates the Pro Care medical device, a cancer symptoms progression monitoring product, including advising on EU-wide GDPR compliance and amendments to relevant business agreements.
- Advising nChain in relation to a variety of issues arising from the relocation of various group entities from Antigua and Barbuda to Switzerland. Our advice has spanned all aspects of the client’s needs with respect to IP, software, copyright, and blockchain-specific data protection matters, as well as strategic issues relating to the client’s future operations.
- Representing UCB with respect to an unfair competition dispute with a competitor in relation to the client’s medicine BIMZELX for the treatment of moderate to severe plaque psoriasis (“PSO”) and research and development tech-work involved.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Dirk Spacek